A polysaccharide composition with therapeutic effect on pet diarrhea

By developing feed additives for Jerusalem artichoke polysaccharide and antibacterial polypeptides, the resistance and toxic side effects of antibiotics and chemical drugs in the treatment of diarrhea in pet dogs has been solved, effectively alleviating diarrhea and intestinal damage, and significantly improving the health status of puppies.

CN118547028BActive Publication Date: 2024-11-01山东晟耀生物科技有限公司 +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202410968526.2
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-07-19
Publication Date
2024-11-01
Estimated Expiration
2044-07-19

AI Technical Summary

Technical Problem

Diarrhea in pet dogs is often accompanied by severe water and electrolyte loss. Existing treatments such as long-term use of antibiotics and chemical synthetic drugs can easily lead to drug resistance and toxic side effects, and lack natural alternatives.

Method used

A feed additive containing Jerusalem artichoke polysaccharide and antibacterial peptides is developed, which is used to relieve diarrhea of ​​puppies and prevent intestinal damage.

Benefits of technology

Jerusalem artichoke polysaccharide can effectively reduce the moisture content of feces of puppies, promote eating and drinking water, and repair intestinal damage. The combined use of polypeptides with Jerusalem artichoke polysaccharide significantly improves the antibacterial effect, significantly improves the symptoms of diarrhea and intestinal health in puppies.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118547028B_ABST
    Figure CN118547028B_ABST
Patent Text Reader

Abstract

The present invention provides a polysaccharide composition with a therapeutic effect on pet diarrhea. The plant polysaccharide is obtained by crushing Jerusalem artichoke dried slices to obtain Jerusalem artichoke powder, defatting and drying the Jerusalem artichoke powder, adding water and protease to extract, concentrating the enzymatic solution, precipitating with alcohol, collecting the precipitate and freeze-drying it. Another aspect of the present invention also provides a polypeptide with antibacterial function, which is isolated from fermentation-type lactic acid bacteria. The Jerusalem artichoke polysaccharide provided by the present invention can relieve diarrhea in piglets and prevent intestinal damage caused by diarrhea. For diarrhea in piglets caused by Escherichia coli, the combination of Jerusalem artichoke polysaccharide and polypeptide can provide more effective protection, and can be promoted and applied as a new feed additive.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of biological products, and in particular relates to a polysaccharide composition having a therapeutic effect on pet diarrhea. Background Art

[0002] In recent years, with the improvement of national consumption level, the change of ideas and concepts, the aging of the population and the growth of single and DINK groups, keeping pets has become a kind of emotional sustenance for people. The number of pets in China will further increase, indicating that the scale of pet breeding in my country is large and continues to grow. Pet dogs are very popular among many pet breeds because of their friendliness, closeness to humans, loyalty and high alertness. They occupy a major position in my country's pets, and the number of pet dogs raised has steadily increased.

[0003] Diarrhea is one of the common diseases in pet dogs, which is often accompanied by vomiting, loss of appetite, weight loss, abdominal pain, lethargy and other disease symptoms. Diarrhea can cause a rapid loss of water and electrolytes in pet dogs, leading to dehydration, which can seriously affect the dog's physiological functions and may even endanger their lives. At present, the treatment of diarrhea in pet dogs is mainly based on antibiotics and chemical synthetic drugs, but long-term and large-scale use can easily lead to drug resistance, toxic side effects and residues in pathogens. It seriously affects the health of pets and even humans. Therefore, the development and utilization of my country's natural plant active substances to replace antibiotics and chemical synthetic drugs is a trend in the development of the pet breeding industry. Summary of the invention

[0004] The invention provides a polysaccharide composition having a therapeutic effect on pet diarrhea, which can relieve diarrhea in puppies and repair intestinal damage caused by diarrhea.

[0005] The invention firstly provides a plant polysaccharide, which is obtained by crushing Jerusalem artichoke dried slices to obtain Jerusalem artichoke powder, defatting and drying the Jerusalem artichoke powder, adding water and enzyme to extract it, concentrating the enzymatic hydrolyzate, precipitating it with alcohol, collecting the precipitate and freeze-drying it;

[0006] The degreasing, as one of the examples, is carried out using petroleum ether;

[0007] The enzyme, as specifically described in the embodiment, is cellulase;

[0008] The plant polysaccharide provided by the present invention can be used as a feed additive to prevent and treat pet diarrhea;

[0009] In another aspect, the present invention also provides a polypeptide with antibacterial function, which is separated from fermentation-type lactic acid bacteria;

[0010] A specific amino acid sequence of the polypeptide is AVDAGEPM (SEQ ID NO: 1).

[0011] In another aspect, the present invention provides a feed additive comprising Jerusalem artichoke polysaccharide and polypeptide Lap-pe037 at pharmacologically effective concentrations.

[0012] The Jerusalem artichoke polysaccharide provided by the present invention can relieve diarrhea in puppies and prevent intestinal damage caused by diarrhea. For diarrhea in puppies caused by Escherichia coli, the combination of Jerusalem artichoke polysaccharide and polypeptide can provide more effective protection, and can be promoted and applied as a new feed additive. BRIEF DESCRIPTION OF THE DRAWINGS

[0013] Figure 1 : Weight changes of puppies in each group during the experimental period (g);

[0014] Figure 2 : Bar graph of fecal water content of puppies in each group;

[0015] Figure 3 : Average food intake of puppies in each group (g);

[0016] Figure 4 : Average water intake of puppies in each group (L);

[0017] Figure 5 : Pathological tissue anatomy of small intestine of puppies in each group;

[0018] Figure 6 : Spectrum of polypeptide G-25 of fermentative lactic acid bacteria Lap037 by dextran gel chromatography;

[0019] Figure 7 : Liquid phase distribution diagram of F2 component after reversed phase high performance liquid chromatography;

[0020] Figure 8 : Changes in weight of puppies in each experimental group (g);

[0021] Fig. 9 : Water content of feces of puppies in each test group;

[0022] Fig.10 : Average food intake of puppies in each experimental group (g);

[0023] Fig.11 : Average water intake of puppies in each experimental group (L);

[0024] Fig.12 : Pathological anatomy of the small intestine of puppies in each experimental group. DETAILED DESCRIPTION

[0025] The present invention is described in detail below in conjunction with embodiments and drawings.

[0026] Example 1: Effect of Jerusalem artichoke polysaccharide on diarrhea in puppies

[0027] 1. Extraction of Jerusalem artichoke polysaccharides

[0028] Jerusalem artichoke slices were crushed with a grinder and passed through a 40-mesh sieve. The dried Jerusalem artichoke powder was placed in a large beaker and precipitated with petroleum ether and allowed to stand overnight to defat. The Jerusalem artichoke powder was dried at 60°C for later use.

[0029] Accurately weigh 5.0 g of the above Jerusalem artichoke dry powder and place it in a 100 mL conical flask. Use distilled water as the extractant, 4% cellulase addition, 25 mL / g liquid-to-solid ratio, 30 min extraction time, and 54 °C extraction temperature to extract Jerusalem artichoke polysaccharide. Inactivate the enzyme at 90 °C for 10 min. Filter, centrifuge, and concentrate the extract. Add 75% ethanol and place it in a 4 °C refrigerator for alcohol precipitation for 12 h. Collect the precipitate and freeze-dry it to obtain Jerusalem artichoke polysaccharide.

[0030] 2. The role of Jerusalem artichoke polysaccharide

[0031] Beagle puppies purchased from an experimental animal farm in Yantai were randomly divided into 5 groups, 10 in each group, namely normal group, model group, treatment group, high polysaccharide concentration group, and low polysaccharide concentration group. From the first day, except for the normal group, the other groups were gavaged with lincomycin hydrochloride injection (15 mg / kg) every morning for 7 consecutive days, and the normal group was replaced with distilled water. In the afternoon, the treatment group was gavaged with the same dose of Tetragenus Bifidobacterium live bacteria tablets (21.06 mg / kg), high polysaccharide (500 mg kg -1 ), low polysaccharide (50 mg kg -1 ) concentration groups were gavaged with different concentrations of Jerusalem artichoke polysaccharide for 14 days. The weight, food intake and water intake of the puppies were measured every day, and the feces of the puppies were collected to measure the water content of the feces and observe the status of the puppies. On the 15th day, the puppies were fasted but not watered. After 12 hours, the puppies were dissected, the small intestinal tissue was collected, and the intestinal tissue pathology was observed.

[0032] The weight of the puppies was recorded every day during the experiment to analyze the average weight changes of each group of puppies during the experiment and to make a line graph of weight changes ( Figure 1 ). The results showed that during the two-week test period, the normal group puppies gained the most weight, the high-concentration polysaccharide group was second only to the treatment group, and the model group gained the least weight. This indicates that the growth of puppies was affected under the induction of lincomycin hydrochloride, while the treatment group and the high-concentration polysaccharide group effectively alleviated this adverse effect.

[0033] Figure 2The results are the fecal water content of each group of puppies. Compared with the normal group, the fecal water content of the model group was significantly higher than that of the normal group. The fecal water content of the treatment group and the high-concentration polysaccharide group was higher than that of the normal group. Compared with the model group, the fecal water content of both groups was significantly reduced (p<0.05). This shows that Jerusalem artichoke polysaccharide can effectively reduce the fecal water content of puppies.

[0034] Figure 3 and Figure 4 The results showed that compared with the normal group, the model group puppies' food and water intake decreased significantly. There was no significant difference between the treatment group and the normal group. Compared with the model group, the average food and water intake of the puppies increased after the intervention of Jerusalem artichoke polysaccharide. This shows that Jerusalem artichoke polysaccharide can effectively help promote puppies' food and water intake.

[0035] exist Figure 5 In the small intestinal tissue sections, it was found that compared with the normal group, the intestinal lining of the model group mice was edematous, loosely arranged and disordered; the intestinal mucosal epithelial cells fell off and dissolved, and some cells showed vacuolation. Compared with the model group, the intestinal epithelial cells of the mice in the low-concentration and high-concentration polysaccharide groups were arranged relatively neatly and intact, confirming that Jerusalem artichoke polysaccharides can effectively alleviate intestinal damage caused by diarrhea in puppies.

[0036] During the experiment, it was found that Jerusalem artichoke polysaccharide has good antibacterial effect on Escherichia coli, Salmonella and other bacteria that can cause canine diarrhea, but the antibacterial effect on Staphylococcus aureus is not obvious. Therefore, Jerusalem artichoke polysaccharide is used in combination with polypeptides to study its antibacterial properties.

[0037] Example 2: Complex effect of Jerusalem artichoke polysaccharide and polypeptide

[0038] 1. Separation and purification of peptides

[0039] The fermentation-type lactic acid bacteria Lap037 isolated from yogurt was inoculated into MRS broth medium under sterile conditions and cultured in a 37 ℃ incubator for 24 hours. Centrifuge at 10000r / min for 10 minutes at 4 ℃, discard the supernatant, take the bacterial sludge precipitate and wash it three times with sterile PBS, centrifuge at 10000r / min for 10 minutes at 4 ℃, and collect the bacterial sludge. Resuspend the bacterial sludge in a sufficient volume of sterile PBS, ultrasonically disrupt it under ice bath (400w, 5s ultrasound, 9s interval) for 20 minutes and centrifuge again. Take the supernatant, and treat the supernatant with an ultrafiltration centrifuge tube. Select three membrane components with molecular weights of 10, 5, and 1kDa. First, connect the 10kDa membrane package to the ultrafiltration system, and the liquid that passes through the cell membrane is a component with a molecular weight less than 10kDa. Pass through the ultrafiltration centrifuge tubes of 5 and 1kDa in sequence, collect the ≤1 kDa permeate components, and freeze-dry. Sephadex G-25 column chromatography was used to further separate and purify the intracellular small molecule peptide mixture components to obtain the Lap037 intracellular small molecule peptide complex.

[0040] Separation and purification of intracellular small peptides with a molecular weight less than 1 kD by ultrafiltration and centrifugation was performed by using dextran gel G-25 chromatography. Figure 6 It can be observed that two components F1 and F2 were separated. Since the component with smaller molecular weight was eluted later, the component with smaller molecular weight F2 was selected for subsequent experiments.

[0041] 10 mg of the intracellular small molecule peptide complex of Lap037 was taken and dissolved in sterile water to prepare a 10 mg / mL solution. The solution was filtered using a 0.45 μmol microporous filter membrane. The solution was then purified using reversed phase high-performance liquid chromatography, and a single chromatographic peak was collected to obtain the Lap037 small molecule peptide. Figure 7 It can be seen that FA and FG account for a larger proportion of the peak area, have a higher content in the Lap037 intracellular small molecule peptide, and have a higher response value. They may be the main effector substances. Therefore, the two components of FA and FG were selected for enrichment for subsequent determination.

[0042] The activity of FA and FG components was detected. The activity of FG component was higher than that of FA, so FG component was selected for amino acid sequence analysis. Liquid chromatography-tandem mass spectrometry was used to identify the polypeptide sequences in the FG component to obtain a total of 48 small molecule peptides, with a molecular weight distribution range of 0.4-1.1KDa. Peptide Ranker software was used to predict the molecular activity of each peptide segment, and 5 peptide segments with high activity were screened. The screened peptide segments were used for the antibacterial activity test of Staphylococcus aureus, and a peptide segment with the best antibacterial activity against Staphylococcus aureus was obtained, named Lap-pe037, and its amino acid sequence was AVDAGEPM (SEQ ID NO: 1).

[0043] 2. Determination of the biological activity of peptides

[0044] Using the microdilution method, the isolated polypeptides and the polysaccharides with added polypeptides were dissolved in sterile water and then diluted with MH medium. The dilution was a gradient dilution centered at 10 μg / mL, and the final concentrations were 160, 80, 40, 20, 10, 5, 2.5, 1.25, and 0.625 μg / mL, respectively. 100 μL of each was added to a polystyrene U-shaped microplate. Staphylococcus aureus cultured in the logarithmic growth phase of MH medium was diluted to 10 with sterile water. 7 cfu / mL as the inoculation solution. Add 5 μL to each well, and the final inoculation volume per well is 10 4 cfu. A blank control well was set on each plate without adding peptide. The results were observed after culturing at 36°C in a biochemical incubator for 12-18 hours.

[0045] The minimum inhibitory concentration (MIC) was determined by the microdilution method. The results showed that the polypeptide with the amino acid sequence of AVDAGEPM had an antibacterial MIC value of 15 μg / mL against Staphylococcus aureus, while the Jerusalem artichoke polysaccharide prepared in the example had an MIC of 60 μg / mL against Staphylococcus aureus, confirming that the polypeptide has a better effect in inhibiting Staphylococcus aureus.

[0046] Example 3: Effect of polysaccharide composition on diarrhea in puppies

[0047] Puppies were infected with Staphylococcus aureus, and treated with polysaccharides and polysaccharides with Lap-pe037 peptide. The results showed that the diarrhea symptoms of the puppies in the treatment group with added peptide were alleviated and they recovered faster than those in the polysaccharide group, which confirmed that the combined use of polysaccharides and peptides was better than that of polysaccharides alone. To verify this conclusion, the following experiment was conducted.

[0048] Weaned puppies of the same size as in Example 1 were randomly divided into 5 groups, each with 10 pups, namely a normal group, a model group, a treatment group, a polysaccharide group, and a polysaccharide-peptide group. Each group was gavaged with Staphylococcus aureus (10 6 CFU / mL), the normal group was gavaged with the same dose of saline, the treatment group was gavaged with colistin sulfate (10 mg / kg) in the afternoon, the polysaccharide group was gavaged with 500 mg / kg of Jerusalem artichoke polysaccharide, and the polysaccharide and polypeptide group was gavaged with 500 mg / kg of polysaccharide + 10 mg / kg of polypeptide for 14 days. The weight, food intake and water intake of the puppies were measured every day, and the feces of the puppies were collected to measure the water content of the feces and observe the status of the puppies.

[0049] Figure 8 The results showed that the normal group gained the most weight, the polysaccharide group gained less weight than the treatment group, and the weight of the polysaccharide polypeptide group continued to be higher than that of the treatment group after 6 days of the experiment, indicating that the polysaccharide polypeptide group had a better therapeutic effect on diarrhea puppies than the treatment group.

[0050] The puppies in the model group developed diarrhea, and the water content of their feces was significantly higher than that in the other groups ( Fig. 9 ), while the fecal water content of the puppies in the normal group, treatment group and polysaccharide polypeptide group had no significant difference (p>0.05), which confirmed that the polysaccharide polypeptide composition had an antagonistic effect on Escherichia coli that caused diarrhea in puppies, and its therapeutic effect on diarrhea in puppies was comparable to that of colistin sulfate.

[0051] Observe the average food and water intake of puppies in each group during the test period ( Fig.10 and Fig.11), the food and water intake of the model group was significantly reduced compared with the normal group (p≤0.05), while after the intervention of polysaccharides, peptides and colistin sulfate, the food and water intake of the puppies was significantly improved. This result was consistent with the weight changes and fecal water content of the puppies, confirming that Jerusalem artichoke polysaccharides have a relieving effect on diarrhea in puppies, and after the addition of peptides, the therapeutic effect was significantly enhanced.

[0052] Fig.12 It can be seen that the villi of the small intestine of the puppies in the normal group were arranged neatly, without wrinkles, with thick intestinal walls and evenly distributed goblet cells, while the villi of the small intestine of the model group were severely damaged, with severe wrinkles and destroyed goblet cells. The villi of the small intestine of the treatment group, polysaccharide group and polysaccharide polypeptide group were relatively complete, especially the small intestinal tissue morphology of the polysaccharide group and the treatment group was not much different.

[0053] The Jerusalem artichoke polysaccharide provided by the present invention has an effect of alleviating diarrhea in puppies and intestinal damage caused by diarrhea. The present invention also provides a polypeptide with antibacterial function, which can be used in combination with Jerusalem artichoke polysaccharide to significantly improve the resistance of puppies to diarrhea-causing bacteria, reduce the harm caused by diarrheal diseases to puppies, and can be promoted and used as a new feed additive.

Claims

1. A polypeptide with antibacterial function, characterized in that: The polypeptide is separated from fermentative lactic acid bacteria, and its amino acid sequence is SEQ ID NO:

1.

2. A feed additive, characterized in that: The feed additive contains plant polysaccharides and the polypeptide according to claim 1, wherein the plant polysaccharide is prepared by crushing Jerusalem artichoke dried slices to obtain Jerusalem artichoke powder, defatting and drying the Jerusalem artichoke powder, adding water and protease to perform enzymatic extraction, concentrating the enzymatic solution and then precipitating with alcohol, collecting the precipitate and freeze-drying it; the defatting is performed using petroleum ether; and the protease is cellulase.

3. A pet food, characterized in that: The pet feed contains the feed additive according to claim 2.